Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.8M Buy
130,110
+2,179
+2% +$252K 0.19% 85
2025
Q4
$13.6M Buy
127,931
+8,554
+7% +$803K 0.17% 96
2025
Q3
$10.1M Sell
119,377
-5,332
-4% -$439K 0.13% 113
2025
Q2
$9.95M Sell
124,709
-3,737
-3% -$297K 0.14% 113
2025
Q1
$11.6M Sell
128,446
-9,244
-7% -$863K 0.18% 98
2024
Q4
$13.7M Buy
137,690
+22,112
+19% +$2.28M 0.2% 93
2024
Q3
$13.3M Buy
115,578
+10,861
+10% +$1.29M 0.2% 89
2024
Q2
$13.3M Buy
104,717
+52,716
+101% +$6.79M 0.22% 80
2024
Q1
$6.86M Sell
52,001
-104
-0.2% -$12.8K 0.18% 83
2023
Q4
$5.72M Buy
52,105
+10,304
+25% +$1.07M 0.16% 94
2023
Q3
$4.33M Sell
41,801
-1,074
-3% -$116K 0.15% 85
2023
Q2
$4.98M Sell
42,875
-792
-2% -$89.9K 0.17% 80
2023
Q1
$4.65M Buy
43,667
+34,408
+372% +$3.71M 0.16% 89
2022
Q4
$1.03M Sell
9,259
-64
-0.7% -$6.54K 0.05% 100
2022
Q3
$803K Buy
9,323
+951
+11% +$84.9K 0.05% 103
2022
Q2
$763K Buy
8,372
+746
+10% +$66.1K 0.04% 106
2022
Q1
$631K Buy
7,626
+1,367
+22% +$108K 0.03% 127
2021
Q4
$480K Buy
6,259
+1,278
+26% +$102K 0.02% 145
2021
Q3
$374K Sell
4,981
-414
-8% -$31.5K 0.02% 156
2021
Q2
$423K Sell
5,395
-148
-3% -$11K 0.02% 146
2021
Q1
$411K Sell
5,543
-488
-8% -$36K 0.03% 132
2020
Q4
$471K Sell
6,031
-1,926
-24% -$147K 0.03% 130
2020
Q3
$630K Buy
7,957
+584
+8% +$45.7K 0.05% 97
2020
Q2
$548K Sell
7,373
-4,445
-38% -$335K 0.05% 109
2020
Q1
$875K Sell
11,818
-1,629
-12% -$128K 0.11% 74
2019
Q4
$1.18M Sell
13,447
-3,278
-20% -$269K 0.12% 79
2019
Q3
$1.35M Buy
16,725
+205
+1% +$16.4K 0.16% 58
2019
Q2
$1.33M Sell
16,520
-337
-2% -$25.8K 0.16% 63
2019
Q1
$1.35M Sell
16,857
-1,823
-10% -$136K 0.16% 61
2018
Q4
$1.37M Sell
18,680
-22,263
-54% -$1.57M 0.2% 54
2018
Q3
$2.79M Sell
40,943
-6,480
-14% -$413K 0.37% 41
2018
Q2
$2.77M Sell
47,423
-5,547
-10% -$313K 0.37% 40
2018
Q1
$2.78M Sell
52,970
-47
-0.1% -$2.54K 0.33% 46
2017
Q4
$2.87M Sell
53,017
-11,376
-18% -$631K 0.35% 47
2017
Q3
$3.95M Buy
64,393
+3,836
+6% +$233K 0.52% 37
2017
Q2
$3.73M Sell
60,557
-446
-0.7% -$27.1K 0.53% 37
2017
Q1
$3.73M Buy
61,003
+4,002
+7% +$243K 0.54% 37
2016
Q4
$3.23M Buy
57,001
+17,522
+44% +$1.03M 0.51% 43
2016
Q3
$2.37M Buy
39,479
+23,718
+150% +$1.39M 0.41% 44
2016
Q2
$872K Buy
15,761
+2,876
+22% +$153K 0.17% 77
2016
Q1
$656K Buy
12,885
+374
+3% +$18.3K 0.13% 83
2015
Q4
$636K Buy
12,511
+717
+6% +$36.1K 0.15% 75
2015
Q3
$561K Buy
11,794
+494
+4% +$26.2K 0.15% 74
2015
Q2
$619K Buy
11,300
+274
+2% +$15.4K 0.15% 74
2015
Q1
$609K Buy
11,026
+384
+4% +$21.7K 0.16% 74
2014
Q4
$581K Buy
10,642
+234
+2% +$13K 0.16% 69
2014
Q3
$593K Buy
10,408
+104
+1% +$5.84K 0.17% 62
2014
Q2
$573K Sell
10,304
-786
-7% -$42.9K 0.16% 65
2014
Q1
$605K Buy
+11,090
New +$574K 0.18% 59

Other funds holding MRK

Choreo LLC's MRK Position: Q1 2026 in Review

Choreo LLC increased its Merck (MRK) stake by 1.7% in Q1 2026, buying an estimated $252K and bringing the position to 130,110 shares worth $15.8M. The position accounts for 0.19% of the portfolio, ranked #85.

Choreo LLC first reported a position in MRK in Q1 2014 and has held it in 49 quarters since. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Choreo LLC held 130,110 shares of Merck worth $15.8M as of Q1 2026.
  • Choreo LLC bought 2,179 Merck shares in Q1 2026, an estimated $252K.
  • Merck made up 0.19% of Choreo LLC's portfolio in Q1 2026, its #85 holding.
  • Choreo LLC first reported a position in Merck in Q1 2014 and has held it in 49 quarters since.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.